2016-06-27 16:51:54 UTC

Freston 2016 Preview: Inflammation and the Development of Metaplasia

June 27, 2016

Learn about session five of the 2016 Freston Conference taking place in Chicago, IL, this August.

This week we continue our preview of the 2016 James W. Freston Conference with insight on session five, Inflammation and the Development of Metaplasia. In case you missed them, make sure to check out previews for the other sessions on origins of metaplasia, stem cells and the GI tract and where metaplasia of the stomach and esophagus originate.

The 2016 conference will take place Aug. 19 to 21 in Chicago, IL. 

Inflammation and the Development of Metaplasia
Session five will elaborate on the key role of inflammation in the development of metaplasia in the stomach and esophagus. Prominent researchers Richard M. Peek, Jr., MD, AGAFRhonda F. Souza, MD, AGAF; and Juanita L. Merchant, MD, PhD will lead attendees in:

  • Understanding how host and microbial genetic interactions augment the risk of developing premalignant lesions.
  • Determining if esophageal microbial interactions with Barrett's metaplasia augments its progression to neoplasia.
  • Examining the hedgehog ligand and its role in parietal cell atrophy transitioning to metaplasia.

Stay tuned to the AGA website for details on session six. To learn more about the conference and to register, visit the conference web page.

Funded by the Takeda Endowment in support of the James W. Freston Single Topic Conference.

A word from Co-Director Stuart Spechler, MD, AGAF

More on Barrett's Esophagus

Principles of GI for the NP and PA

Aug. 10, 2018

Hear from the experts as they provide you with critical updates on treating and managing patients with a variety of GI disorders.

2018 AGA Postgraduate Course

June 2, 2018

Secure your spot for this clinically focused, multi-topic course that offers immediately applicable information. Held in conjunction with DDW®. Save $75 when you register by April 18.

How to Talk with Your Patients About PPIs and Cognitive Decline

Feb. 22, 2018

More information clearing concerns about the use of proton pump inhibitors (PPIs).